Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning

World Health Organization (WHO). Coronavirus Disease 2019 (COVID-19) Situation Report: Weekly epidemiological Update on COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Johns Hopkins University & Medicine: Coronavirus Resource Center https://coronavirus.jhu.edu. Hsu CY, Lai CC, Yeh YP, Chuane CC, Chen HH. Progression from Pneumonia to ARDS as a Predictor for Fatal COVID-19. J Infect Public Health 2021; 14: 504-507. https:/doi.org/10.1016/j.jiph.2020.12.026. Aslan, 2021, Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management, Pneumonia, 13, 1, 10.1186/s41479-021-00092-9 Robinsona, 2022, COVID-19 therapeutics: Challenges and directions for the future, PNAS, 119, 1 Rando HM, Wellhausen N, Ghosh S, Lee AJ, Dattoli AA, Hu F, et al. Greene CS. Identification and Development of Therapeutics for COVID-19. mSystems 2021; 6: 1–52. https://journals.asm.org/doi/10.1128/mSystems.00233-21. Tay, 2020, The trinity of COVID-19: Immunity, inflammation and intervention, Nat Rev Immunol, 20, 363, 10.1038/s41577-020-0311-8 Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, 130, 2620, 10.1172/JCI137244 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Kim, 2020, Viral load kinetics of SARS–CoV–2 infection in first two patients in Korea, J Korean Med Sci, 35, e86, 10.3346/jkms.2020.35.e86 Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019–nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020; 63(3): 364–374. https://doi.org/0.1007/s11427-020-1643-8. Pan, 2020, Viral load of SARS-CoV-2 in clinical samples, Lancet Infect Dis, 20, 411, 10.1016/S1473-3099(20)30113-4 Phan, 2020, Importation and human-to-human transmission of a novel coronavirus in Vietnam, N Engl J Med, 382, 872, 10.1056/NEJMc2001272 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Hirano, 2020, COVID–19: A new virus, but a familiar receptor and cytokine release syndrome, Immunity, 52, 731, 10.1016/j.immuni.2020.04.003 Mahmudpour, 2020, COVID–19 cytokine storm: The anger of inflammation, Cytokine, 133, 10.1016/j.cyto.2020.155151 McGonagle, 2020, The role of cytokines including interleukin–6 in COVID–19 induced pneumonia and macrophage activation syndrome-like disease, Autoimmun Rev, 19, 10.1016/j.autrev.2020.102537 Hojyo, 2020, How COVID–19 induces cytokine storm with high mortality, Inflamm Regen, 40, 37, 10.1186/s41232-020-00146-3 Zhang, 2007, Cytokines, inflammation and pain, Int Anesthesiol Clin, 45, 27, 10.1097/AIA.0b013e318034194e Ragab, 2020, The COVID–19 cytokine storm; What we know so far, Front Immunol, 11, 1446, 10.3389/fimmu.2020.01446 Tisoncik, 2012, Into the eye of the cytokine storm, Microbiol Molecular Biol Rev, 76, 16, 10.1128/MMBR.05015-11 Frank E, Hall MA, Whitten IH. The WEKA Workbench. Online Appendix for Data Mining: Practical Machine Learning Tools and Techniques, Morgan Kaufmann, Fourth Edition, 2016; https://www.cs.waikato.ac.nz/ml/weka/book.html. NCI/CADD Group. Online SMILES Translator and Structure File Generator. National Institutes of Health, U.S. Department of Health and Human Services, National Cancer Institute. 21 Apr. 2020; https://cactus.nci.nih.gov/translate (Last accessed 25 May 2022). Yap, 2010, PaDEL-descriptor: An open-source software to calculate molecular descriptors and fingerprints, J Comput Chem, 32, 1466, 10.1002/jcc.21707 WEKA 3.8.5 University of Waikato; software download; https://www.cs.waikato.ac.nz/∼ml/weka/. (a) Irwin JJ, Soichet BK. ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005 45(1): 177-182. https://doi.org/ 10.1021/ci049714+. (b) Sterling T, Irwin JJ. ZINC 15--Ligand discovery for everyone. J Chem Inf Model 2015 55(11): 2324-2337. https://doi.org/10.1021/acs.jcim.5b00559. (c) https://zinc.docking.org/ (Last accessed 25 May 2022). (a) Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol 2015; 1263: 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19; (b) Python Prescription: Virtual Screening Tool. https://pyrx.sourceforge.io/ (Last accessed 23 May 2022). Dassault Systemes, Free Download: BIOVIA Discovery Studio Visualizer. https://discover.3ds.com/discovery-studio-visualizer-download (Last accessed 27 May 2022). (a) Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res 2000; 28(1): 235–242. https://doi.org/10.1093/nar/28.1.235; (b) RCSB PDB: Protein Data Bank. http://www.rcsb.org/ (Last accessed 23 May 2022). Mukund, 2019, Molecular docking analysis of nuclear factor–κB and genistein interaction in the context of breast cancer, Bioinformation, 15, 11, 10.6026/97320630015011 Fu, 2020, Both Boceprevir and GC376 efficaciously inhibit SARS–CoV–2 by targeting its main protease, Nat Commun, 11, 4417, 10.1038/s41467-020-18233-x Tsiakos, 2021, Early start of oral clarithromycin is associated with better outcome in COVID–19 of moderate severity: The ACHIEVE Open-Label Single-Arm Trial, Infect Dis Ther, 10, 2333, 10.1007/s40121-021-00505-8 Yamamoto, 2021, Efficacy of clarithromycin in patients with mild COVID 19 pneumonia not receiving oxygen administration: Protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID 19 study), BMJ Open, 11, e053325, 10.1136/bmjopen-2021-053325